Satellos to Participate in Four September Institutional and Retail Investor Conferences

TORONTO--(BUSINESS WIRE)--Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, announced today that members of its senior management team will participate in the following investor events in September: Wells Fargo Healthcare Conference Format: Participation in 1x1 meetings Date: Wednesday, Sept. 3 Location: Boston, MA Cantor Fitzgerald Global Healthcare